The incredibly hard work and overwhelming success of the Cheshire and Merseyside Medicines Optimisation Programme was recognised by the Healthcare Financial Management Association (HFMA) at the 2019 National Healthcare Finance Awards.
The programme, which was delivered in collaboration between the Cheshire and Merseyside Health and Care Partnership and Mersey Internal Audit Agency (MIAA), was announced winner of the Value and Innovation Award at HFMA’s annual conference in London.
The category highlights the schemes and projects across the country that are driving innovation, whilst creating significant value for money for the health and care economy. The programme was up against steep competition, with St Helens Cares and Leeds Teaching Hospitals NHS Trust also included in the shortlist.
The programme – the first of its kind that works across all parts of the regional health economy – brought together pharmacists from Cheshire and Merseyside, along with colleagues from primary care, specialised commissioning, Clinical Commissioning Groups (CCGs) and mental health teams, to ensure a collaborative approach to medicines optimisation.
This collaborative approach to creating value is a central facet of the Health and Care Partnership’s Collaboration at Scale (CaS) programme. By tackling a number of pressing issues faced by NHS organisations across Cheshire and Merseyside from the perspective of a partnership, rather than in individual places, positive outcomes can be applied across the entire network, which results in a much more consistent local health and care economy.
Terry Whalley, Programme Director for Cheshire and Merseyside Health and Care Partnership’s Collaboration at Scale programme, said:
“There has been a huge amount of hard work from pharmacy colleagues across Cheshire and Merseyside, collaborating at scale to deliver real value for patients and taxpayers. It’s fantastic to see this recognised by the HFMA at their national awards. I’m hoping this will help to inspire more collaboration in other areas.
“This programme received £380,000 of investment from the Health and Care Partnership, which will result in over £2.5 million in savings in the 2019/20 financial year. This kind of saving is exactly why programmes like CaS are so important to partnership working, and we look forward to seeing more good news like this coming from our Partnership in the future.”
Helen Poulter-Clark, Chief Pharmacist at The Clatterbridge Cancer Centre and SRO of the medicines optimisation programme and Chris Harrop, Commercial Director and Programme Lead, said:
“This award recognises the efforts of our hardworking colleagues from across the area, who have committed their time, knowledge and skills to collaborating on this region-wide programme. We are exceptionally proud to be involved, and not only contribute to sizeable savings in the local health economy, but also provide the very best outcomes for our patients across Cheshire and Merseyside.”
Bill Gregory, President of HFMA and Chief Finance Officer at Lancashire and South Cumbria NHS Foundation Trust, said:
“We were pleased to receive a very high-calibre of entries for the National Healthcare Finance Awards. NHS staff across the country are working extremely hard to innovate, lead by example, and ensure good quality healthcare. It is important to celebrate their commitment and the dedication of sector leaders. Huge congratulations to Cheshire and Merseyside Health and Care Partnership and MIAA for this well-deserved achievement, which once again highlights the strength of our NHS staff.”